Are you a media representative looking for content on Bayer? This section provides news, press photos and more.
News
May 21, 2026
Not intended for U.S. and UK Media
U.S. FDA grants Priority Review for finerenone in chronic kidney disease associated with type 1 diabetes
May 19, 2026
Not intended for U.S. and UK Media
New drug applications for Bayer’s FXIa inhibitor accepted by U.S. Food and Drug Administration under Priority Review and by Japan’s Ministry of Health, Labour and Welfare
May 18, 2026
Not intended for U.S. and UK Media
FDA grants sevabertinib Priority Review as a first-line treatment for patients with HER2-mutant non-small cell lung cancer
In Focus
Our Services
Publications
Get easy access to the different reports, magazines and brochures from Bayer.
Publikationen
Discover more
